Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Supplements

Clinical Monograph: Addressing the Challenges of Dysphagia in Long-Term Care Residents (Sponsored)
Clinical Monograph: Addressing the Challenges of Dysphagia in Long-Term Care Residents (Sponsored)
Click on the PDF to the right to view the complete clinical monograph.   
Product Perspective: Kapspargo Sprinkle
Product Perspective: Kapspargo Sprinkle
Click on the PDF to access the complete product perspective and spotlight.   
Product Monograph: FreeStyle Libre 2 System
Product Monograph: FreeStyle Libre 2 System
Click on the PDF to access the complete product monograph. Learn more at www.FreeStyleLibre.us/FRMC  
Product Bulletin: Rybelsus
Product Bulletin: Rybelsus
Click on the PDF to access the complete product bulletin.   
Continuous Glucose Monitoring With Dexcom G6 (Sponsored)
Continuous Glucose Monitoring With Dexcom G6 (Sponsored)
Click on the PDF to access the complete Product Monograph  

Advertisement

Advertisement

Advertisement

What's Trending?

News Connection
Patients’ Use of Multiple Acute Care Facilities
02/15/2011

Tori Socha

Tori Socha
Timely access to patients’ health information is a key component in delivering effective and safe medical treatment.
Timely access to patients’ health information is a key component in delivering effective and safe medical treatment.
Timely access to patients’...
02/15/2011
First Report Managed Care
News
TAVR may help recovery of cognitive function
10/19/2016
By David DouglasNEW YORK (Reuters Health) -...
By David DouglasNEW YORK (Reuters Health) -...
...
10/19/2016
Population Health
News
FDA Approves New Drug to Treat Irritable Bowel Syndrome and Constipation
10/16/2012
On August 30, 2012, the FDA approved Linzess (linaclotide) for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adults. Constipation is one of the most common gastrointestinal...
On August 30, 2012, the FDA approved Linzess (linaclotide) for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adults. Constipation is one of the most common gastrointestinal...
On August 30, 2012, the FDA...
10/16/2012
Annals of Long-Term Care
Conference Insider
Zarxio Switching Fails to Meet Budget Impact Model Expectations
05/10/2017
According to research presented at the AMCP 2017 Annual Meeting, Zarxio (filgrastim-sndz; Sandoz) cost savings, predicted using a budget impact model, failed to meet the expectations of researchers due to the drug’s higher price.
According to research presented at the AMCP 2017 Annual Meeting, Zarxio (filgrastim-sndz; Sandoz) cost savings, predicted using a budget impact model, failed to meet the expectations of researchers due to the drug’s higher price.
According to research presented...
05/10/2017
First Report Managed Care
News
Welcome to the AES 2017 Annual Meeting
11/29/2017
The 71st American Epilepsy Society (AES) Annual Meeting is taking place in Washington, DC, from December 1st through December 5th at the Walter E Washington Convention Center.
The 71st American Epilepsy Society (AES) Annual Meeting is taking place in Washington, DC, from December 1st through December 5th at the Walter E Washington Convention Center.
The 71st American Epilepsy...
11/29/2017
Annals of Long-Term Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use